Active Pharmaceutical Ingredients producer Lasa Supergenerics on Thursday said it has started distributing Arsenic album 30 medicines to the tune of 2.5 lakh doses initially and going forward, the company will distribute 10 lakh doses free of cost in COVID-19 affected areas.
Lasa has commenced its efforts to support the government to prevent the deadly COVID-19 by way of distributing Arsenic album 30 medicines to the tune of 2.5 lakh doses initially which may possibly prevent approximately 1 lakh people from contracting the deadly virus, the company said in a regulatory filing.
The company further said this is the initial phase of distribution and going forward "we shall execute distribution of 10 lakh doses free of cost in the affected areas".
"To distribute the above we have already obtained requisite permission from Brihanmumbai Municipal Corporation," the company said.
Additionally, to support the fight against coronavirus the company has distributed around 10,000 liters of liquid disinfectant for sanitization in rural areas along with soaps, gloves, sanitizers, thermometers, masks, lunch packets, ration and contribution to PM CARES Fund and CM relief fund, the filing said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
